1. Home
  2. ALLR vs WETH Comparison

ALLR vs WETH Comparison

Compare ALLR & WETH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allarity Therapeutics Inc.

ALLR

Allarity Therapeutics Inc.

N/A

Current Price

$0.87

Market Cap

19.3M

Sector

Health Care

ML Signal

N/A

WETH

Wetouch Technology Inc.

N/A

Current Price

$0.86

Market Cap

16.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ALLR
WETH
Founded
2004
1992
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.3M
16.9M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
ALLR
WETH
Price
$0.87
$0.86
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 114.8K
67.2K
Earning Date
11-13-2026
11-11-2026
Dividend Yield
N/A
★ 4.49%
EPS Growth
N/A
★ 15.38
EPS
N/A
★ 0.50
Revenue
$320,000.00
★ $45,136,818.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$1.82
Revenue Growth
N/A
★ 6.76
52 Week Low
$0.77
$0.82
52 Week High
$1.84
$2.97

Technical Indicators

Market Signals
Indicator
ALLR
WETH
Relative Strength Index (RSI) 39.12 33.76
Support Level $0.79 N/A
Resistance Level $1.45 $1.27
Average True Range (ATR) 0.07 0.09
MACD 0.01 -0.00
Stochastic Oscillator 43.87 16.19

Price Performance

Historical Comparison
ALLR
WETH

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States. It is focused on the clinical development of its lead program: Stenoparib, which is being co-developed with a drug specific DRP companion diagnostic.

About WETH Wetouch Technology Inc.

Wetouch Technology Inc is a business of research and development, manufacturing, and distribution of touchscreen displays to customers both in the PRC and overseas. The touchscreen products, which are manufactured by the Company, are mainly for use in financial terminals, automotive, Point of Sales, gaming, lottery, medical, Human-Machine Interface (HMI), and other specialized industries. The company sells touchscreen products both domestically in China and internationally, covering areas in Mainland China, including but not limited to the eastern, southern, northern, and southwest regions of Mainland China, Taiwan, South Korea, Germany, and other countries.

Share on Social Networks: